The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
invasiveness at concentrations representative <strong>of</strong> human exposure (10 -7 M) but had<br />
no effect on resistance to anoikis. DBP had no effect on invasiveness or resistance to<br />
anoikis while its major metabolite increased resistance to anoikis at concentrations<br />
representative <strong>of</strong> human exposure (10 -8 M). <strong>The</strong>refore, at concentrations relevant to<br />
human exposure, endocrine toxicants may promote breast cancer progression and<br />
metastasis by altering resistance to anoikis and invasiveness.<br />
229 ENVIRONMENTAL CHEMICALS AND BREAST<br />
CANCER—GEOGRAPHIC ASSOCIATION BETWEEN<br />
LIVESTOCK WASTE, CONTAMINATED SURFACE<br />
WATER, AND BREAST CANCER INCIDENCE IN THE<br />
SAN FRANCISCO BAY AREA.<br />
H. Larson 1 , M. Mun 1 , W. Onyenwe 1 and D. E. Johnson 1, 2 . 1 Nutritional Science<br />
& <strong>Toxicology</strong>, University <strong>of</strong> California Berkeley, Berkeley, CA and 2 California Breast<br />
Cancer & Chemicals Policy Project, San Francisco, CA.<br />
<strong>The</strong> aim <strong>of</strong> this study was to introduce a novel approach to understanding the high<br />
incidence <strong>of</strong> breast cancer in the San Francisco Bay area and, in particular, Marin<br />
County, which has the highest incidence. Geographical and environmental pollution<br />
data were compared with breast cancer statistics in order to produce a<br />
“geomedical” image <strong>of</strong> the disease and possible association with environmental contaminants.<br />
Technologies and information sources included ArcGIS9, ArcMap, NCI<br />
State Cancer Pr<strong>of</strong>iles, Scorecard, and Census <strong>of</strong> Agriculture Pr<strong>of</strong>iles by county. A<br />
strong association occurred between breast cancer incidence and animal waste pollution<br />
from livestock, making this the primary comparative focus. Accordingly,<br />
livestock waste pollution and breast cancer incidence rates were compared among<br />
eight counties in the California Bay Area: Marin, Alameda, Contra Costa, Napa,<br />
San Francisco, San Mateo, Santa Clara, Solano, and Sonoma. Two non-California<br />
counties (King County, WA; Delaware County, OH) were also selected for analysis<br />
based on population demographics, water sources, and potential surface contamination<br />
from livestock waste. <strong>The</strong> results demonstrate a visible correlation between<br />
high amounts <strong>of</strong> animal waste and high incidence rates <strong>of</strong> breast cancer. <strong>The</strong> definitive<br />
causal link has yet to be identified, but one possible explanation is that improperly<br />
stored waste from large, industrial livestock farms may be contaminating<br />
surface water sources. Farm animals are typically treated with hormones and antibiotics<br />
to promote growth, but these treatments also increase the amount <strong>of</strong> hormonal<br />
waste excreted. In Marin County, surface water is the primary source <strong>of</strong><br />
drinking water; however, adequate well-controlled studies on hormone contamination<br />
and persistence in the supply do not exist.<br />
230 NOVEL P450 REDUCTASE KNOCKOUT MOUSE<br />
MODELS FOR STUDYING CHEMICAL<br />
CARCINOGENESIS IN THE MAMMARY GLAND.<br />
Y. Yao 1 , S. Liu 1 , W. Yang 1 , B. Moorthy 2 , X. Ding 1 and J. Gu 1 . 1 Wadsworth<br />
Center, New York State Department <strong>of</strong> Health, and School <strong>of</strong> Public Health, State<br />
University <strong>of</strong> New York at Albany, Albany, NY and 2 Baylor College <strong>of</strong> Medicine,<br />
Houston, TX.<br />
Microsomal P450 (P450) enzymes play a critical role in the metabolic activation <strong>of</strong><br />
chemical procarcinogens. However, it has been difficult to determine whether, following<br />
systemic exposure to a given procarcinogen (such as 7,12dimethylbenz[a]anthracene,<br />
DMBA), the bulk <strong>of</strong> the activated carcinogen, or its<br />
DNA adducts, in the breast tissue is derived from local metabolism or from the<br />
liver. <strong>The</strong> aim <strong>of</strong> this study is to test the hypothesis that target-tissue P450-mediated<br />
metabolic activation plays an important role in DMBA-induced formation <strong>of</strong><br />
DNA adducts in the mammary gland (MG). This hypothesis is tested in mouse<br />
models, by modulating P450 activities in the liver, in all extrahepatic tissues, or in<br />
the MG alone, through conditional deletion (or suppression) <strong>of</strong> the gene for P450<br />
reductase (Cpr), an enzyme required for the activity <strong>of</strong> all microsomal P450 enzymes.<br />
Initial studies on the liver-specific Cpr-null mouse indicated that hepatic<br />
P450 enzymes do not contribute significantly to DMBA-induced DNA-adduct<br />
formation in the MG, as determined by [32]P-postlabeling. For a more direct determination<br />
<strong>of</strong> the role <strong>of</strong> MG P450 enzymes in DNA-adduct formation, we have<br />
also been studying an extrahepatic-Cpr-low mouse, which has normal P450 activities<br />
in the liver, but much suppressed P450 activities in all extrahepatic tissues. <strong>The</strong><br />
level <strong>of</strong> CPR protein in MG microsomes from the extrahepatic-Cpr-low mouse was<br />
found to be ~10% <strong>of</strong> the levels found in wild-type mice. In addition, a MG-Cprnull<br />
mouse model, expected to have tissue-specific suppression <strong>of</strong> P450 activities in<br />
the MG, is also being prepared, by crossbreeding Cpr-lox mouse with the MMTV-<br />
Cre mouse. <strong>The</strong> extrahepatic-Cpr-low mouse and the MG-Cpr-null mouse will be<br />
studied for determinations <strong>of</strong> the contributions <strong>of</strong> target tissue metabolic activation<br />
to DMBA-induced DNA adduct formation in the MG. (Supported in part by NIH<br />
grant ES018884)<br />
231 IDENTIFYING INHIBITION PATHWAYS OF MAMMARY<br />
CANCER STEM CELLS BY CHEMICAL GENETICS.<br />
D. Castro, J. Maurer and R. Oshima. Tumor Development Program, Sanford-<br />
Burnham Medical Research Institute, La Jolla, CA.<br />
Studies have identified subpopulations <strong>of</strong> cells within tumors that drive tumorigenesis,<br />
termed cancer stem cells (CSCs). CSCs have also displayed increased resistance<br />
to traditional therapies. This persistent viability permits the regeneration <strong>of</strong> the<br />
tumor and contributes to the failure <strong>of</strong> chemotherapeutics. We have isolated mammary<br />
cancer stem cells from the mouse mammary tumor virus (MMTV)-Wnt-1<br />
transgenic model <strong>of</strong> breast cancer. <strong>The</strong>se tumorigenic progenitor cells express markers<br />
<strong>of</strong> both luminal (keratin 8) and basal cells (keratin 14) as well as stem cell associated<br />
markers for CD24, CD29, and CD49f. Cell cultures enriched for the bipotent<br />
progenitor (K8 + ,K14 + ) have generated tumors with the differentiated<br />
morphology <strong>of</strong> the tumor <strong>of</strong> origin from as few as a single cell. We employed a small<br />
library <strong>of</strong> 243 annotated kinase inhibitors in an effort to establish a chemical sensitivity<br />
pr<strong>of</strong>ile towards the CSCs. Our initial screen with a dose <strong>of</strong> 1 μM identified<br />
35 compounds with the ability to reduce cell survival by >50% after a 3 day incubation<br />
period. A cluster <strong>of</strong> 7 annotated Protein kinase C (PKC) inhibitors exhibited<br />
the most dramatic effects on cell survival. <strong>The</strong> hydroxylated form <strong>of</strong> staurosporine,<br />
(UCN-01), a derived anti-cancer agent, suppressed growth at submicromolar concentrations<br />
and produced an IC 50 <strong>of</strong> 47 nM. <strong>The</strong> concerted effectiveness <strong>of</strong> the<br />
PKC inhibitors at low nanomolar concentrations indicate an inhibitory role for<br />
PKC and its downstream targets. In order to demonstrate selective toxicity for our<br />
CSCs, we are currently evaluating the effectiveness <strong>of</strong> validated targets on representative<br />
mammary cancer cell lines. We also plan to implement this screening method<br />
with a small library <strong>of</strong> the most current FDA-approved anti-cancer drugs. <strong>The</strong><br />
chemical sensitivity pr<strong>of</strong>ile <strong>of</strong> our CSCs will eventually be applied to human cancer<br />
cells to identify those that may be regulated in a similar way.<br />
232 SEVERE URINARY BLADDER CYTOTOXICITY AND<br />
REGENERATIVE HYPERPLASIA WITH DOSE<br />
RESPONSE INDUCED BY ARSENITE IN ARSENIC (+3<br />
OXIDATION STATE) METHYLTRANSFERASE<br />
KNOCKOUT MICE.<br />
M. Yokohira 2, 1 , L. L. Arnold 2 , K. L. Pennington 2 , S. Suzuki 2 , S. Kakiuchi-<br />
Kiyota 2 , K. Herbin-Davis 3 , D. J. Thomas 3 , K. Imaida 1 and S. M. Cohen 2 .<br />
1 Oncopathology, Kagawa University, Faculty <strong>of</strong> Medicine, Kita-gun, Kagawa, Japan,<br />
2 Pathology and Microbiology, University <strong>of</strong> Nebraska Medical Center, Omaha, NE<br />
and 3 Pharmacokinetics Branch, Integrated Systems <strong>Toxicology</strong> Division, National<br />
Health and Environmental Effects Research Laboratory, U.S. EPA, Omaha, NE.<br />
Arsenic (+3 oxidation state) methyltransferase (As3mt) catalyzes reactions converting<br />
inorganic arsenic to methylated metabolites. We evaluated whether the As3mt<br />
null genotype in mice modifies cytotoxic and proliferative effects in urinary bladders<br />
<strong>of</strong> wild type mice after inorganic arsenic exposure. Previously we showed female<br />
As3mt KO mice treated with diet containing 0, 100 or 150 ppm arsenic as arsenite<br />
(AsIII) had systemic toxicity and significant effects on the urothelium. In the<br />
present study, we determined if the cytotoxic and proliferative effects <strong>of</strong> AsIII on<br />
the urothelium are dose dependent over 4 weeks <strong>of</strong> treatment. Female wild type<br />
C57BL/6 mice and As3mt KO mice were divided into 5 groups each (n=7) with<br />
free access to drinking water containing 0, 1, 10, 25 or 50 ppm arsenic as AsIII for<br />
4 weeks. At sacrifice, urinary bladders <strong>of</strong> both As3mt KO and wild type mice<br />
showed hyperplasia by light microscopy. In As3mt KO mice, numerous cytoplasmic<br />
and nuclear granules were present in all urothelial layers and were more abundant<br />
and larger than in wild type mice. In As3mt KO mice, livers showed mild<br />
acute inflammation and kidneys showed hydronephrosis. Thus, diminished arsenic<br />
methylation in As3mt KO mice exacerbates the effects <strong>of</strong> AsIII on the bladder epithelium,<br />
showing that altered kinetic and dynamic behavior <strong>of</strong> arsenic can affect its<br />
systemic and urothelial toxicity.<br />
233 TUMORS AND PROLIFERATIVE LESIONS IN ADULT<br />
OFFSPRING AFTER MATERNAL EXPOSURE TO<br />
METHYLARSONOUS ACID DURING GESTATION IN<br />
CD1 MICE.<br />
M. Waalkes 2, 1 , B. A. Diwan 3 , E. J. Tokar 2, 1 and D. J. Thomas 4 . 1 NCI at NIEHS,<br />
Research Triangle Park, NC, 2 NTP, NIEHS, Research Triangle Park, NC, 3 IRSP,<br />
SAIC, NCI, Frederick, MD and 4 U.S. EPA, Research Triangle Park, NC.<br />
Inorganic arsenic exposure is carcinogenic in humans and rodents. When pregnant<br />
mice are exposed to inorganic arsenic in the drinking water their <strong>of</strong>fspring, when<br />
adults, develop tumors and proliferative lesions at several sites, such as lung, liver,<br />
SOT 2011 ANNUAL MEETING 49